MedTrace Logo

Chemical Debridement and Leg Ulcers

NCT06652360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-02-24

No results posted yet for this study

Summary

A pilot study to investigate the relative effectiveness and safety of chemical wound debridement and curettage in the treatment of venous and mixed aetiology leg ulcers.

Conditions

  • Venous Leg Ulcers
  • Mixed Ulcer

Interventions

DEVICE

Chemical Debridement

The chemical debridement is a dehydrating agent in a gel shape that will dry out the woundbed and biofilm.

DEVICE

Curettage debridement

The use of a currette will clean the wound bed. Debridement by mechanically removing the necrotic tissue and biofilm. This is performed confrom the standard of care standards.

Sponsors & Collaborators

  • DEBx Medical B.V.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2025-12-24
Completion
2026-02-23

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06652360 on ClinicalTrials.gov